Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News and Events
Nuoret suolistosyöpäpotilaat: potilas-tutkijatapaaminen
Oletko sairastunut suolistosyöpään nuorena? Tule tapaamaan muita nuorena sairastuneita ja suolistosyöpää tutkivia asiantuntijoita. Colores, HUS ja iCAN järjestävät torstaina 17.9.2026 klo…
BioFinland Pitching Competition motivated Arina Värä to develop and pitch her business idea based on her iCANDOC doctoral research project – with winning results
Arina Värä, a doctoral researcher at iCANDOC Doctoral Education Pilot in Precision Cancer Medicine studies Boron neutron capture therapy (BNCT)…
iCAN Science Seminar with Cory Abate-Shen on From Mouse to Man: Learning about human prostate cancer by studying genetically engineered mouse models
Welcome to the iCAN Science Seminar with Cory Abate-Shen on From Mouse to Man: Learning about human prostate cancer by studying genetically engineered…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding

